Disclosures for "Rimegepant for the Prevention of Episodic Migraine in Adults with Prior Inadequate Response to Oral Preventatives: Results from a 12-week Open-label Extension Phase of a Randomized, Placebo-controlled Trial"
-
Dr. Pozo-Rosich has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for AbbVie. Dr. Pozo-Rosich has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Teva Pharmaceuticals. Dr. Pozo-Rosich has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. Dr. Pozo-Rosich has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Dr. Pozo-Rosich has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Organon. Dr. Pozo-Rosich has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dr. Reddy's. Dr. Pozo-Rosich has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Sociedad Española Neurologia.
-
Dr. Gien-Lopez has nothing to disclose.
-
Author has nothing to disclose
-
Dr. Aslan has received personal compensation for serving as an employee of Pfizer. Dr. Aslan has stock in Pfizer Inc.
-
Ms. Seehra has stock in Pfizer.
-
Dr. Thiry has received personal compensation for serving as an employee of Pfizer. Dr. Thiry has received personal compensation for serving as an employee of Biohaven Pharmaceuticals. Dr. Thiry has stock in Pfizer. Dr. Thiry has stock in Biohaven Pharmaceuticals.
-
Lucy Abraham has received personal compensation for serving as an employee of Pfizer R&D UK Ltd. Lucy Abraham has stock in Pfizer R&D UK Ltd.
-
Dr. Ramirez has received personal compensation for serving as an employee of Pfizer.
-
Robert Fountaine has received personal compensation for serving as an employee of Pfizer, Inc.. Robert Fountaine has stock in Pfizer, Inc. Robert Fountaine has stock in Viatris, Inc.
-
Dr. Fullerton has received personal compensation for serving as an employee of Pfizer. Dr. Fullerton has stock in Pfizer.